The frequency and structure of comorbid infections in patients with spondyloarthritis (preliminary own data)

Introduction. Data on the frequency of comorbid infections (CI) in patients with spondyloarthritis (SpA) are few and contradictory. Objective. The aim of the study was to study the frequency and structure of CI in the inpatient population of SpA patients in the course of a one-moment retrospective s...

Full description

Bibliographic Details
Main Authors: M. M. Baranova, N. V. Muravyeva, B. S. Belov
Format: Article
Language:Russian
Published: Remedium Group LLC 2021-03-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/6020
_version_ 1797841493092728832
author M. M. Baranova
N. V. Muravyeva
B. S. Belov
author_facet M. M. Baranova
N. V. Muravyeva
B. S. Belov
author_sort M. M. Baranova
collection DOAJ
description Introduction. Data on the frequency of comorbid infections (CI) in patients with spondyloarthritis (SpA) are few and contradictory. Objective. The aim of the study was to study the frequency and structure of CI in the inpatient population of SpA patients in the course of a one-moment retrospective study.Subjects and methods. The study included 205 patients with SPA: 119 men, 86 women, the age of patients was 39.02 ± 12.2 years, the duration of the disease was 129.3 ± 104.3 months. Ankylosing spondylitis was diagnosed in 133 patients, psoriatic arthritis in 55, spondyloarthritis associated with Crohn’s disease – in 1, undifferentiated spondyloarthritis – in 16. Most patients, along with nonsteroidal anti-inflammatory drugs, received glucocorticoids, basic anti-inflammatory drugs, and biological drugs. Patients were interviewed by a research doctor with the completion of a unified questionnaire, additional data were obtained from medical documentation.Results. 20% of patients reported more frequent CI development after the SpA debut. 28.7% of patients reported a more severe course of previously observed CI. Temporary discontinuation of therapy due to the development of CI occurred in 25.4% of patients. Exacerbation of SpA after CI was diagnosed in 40% of patients. In general, the leading place in the structure of CI was occupied by infections of the respiratory tract and ENT-organs, the second place belonged to herpes-viral infections. Serious CI accounted for 6.8% of all cases of CI. In SpA patients receiving immunosuppressive therapy, there was an increase in the frequency of acute nasopharyngitis, sinusitis, acute bronchitis, pneumonia and herpes-viral infections. However, cases of CI have also been reported in patients who have never received immuno-suppressive drugs.Conclusion. The data obtained indicate the important of the problem of CI in SpA. Further studies are needed on large samples of patients in order to find significant risk factors for CI, study their relationship with clinical characteristics and influence on the course of SpA.
first_indexed 2024-04-09T16:31:42Z
format Article
id doaj.art-4d1e18a68cad48e0b490ff3f3edb8348
institution Directory Open Access Journal
issn 2079-701X
2658-5790
language Russian
last_indexed 2024-04-09T16:31:42Z
publishDate 2021-03-01
publisher Remedium Group LLC
record_format Article
series Медицинский совет
spelling doaj.art-4d1e18a68cad48e0b490ff3f3edb83482023-04-23T06:57:03ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902021-03-010212212610.21518/2079-701X-2021-2-122-1265470The frequency and structure of comorbid infections in patients with spondyloarthritis (preliminary own data)M. M. Baranova0N. V. Muravyeva1B. S. Belov2Nasonova Research Institute of RheumatologyNasonova Research Institute of RheumatologyNasonova Research Institute of RheumatologyIntroduction. Data on the frequency of comorbid infections (CI) in patients with spondyloarthritis (SpA) are few and contradictory. Objective. The aim of the study was to study the frequency and structure of CI in the inpatient population of SpA patients in the course of a one-moment retrospective study.Subjects and methods. The study included 205 patients with SPA: 119 men, 86 women, the age of patients was 39.02 ± 12.2 years, the duration of the disease was 129.3 ± 104.3 months. Ankylosing spondylitis was diagnosed in 133 patients, psoriatic arthritis in 55, spondyloarthritis associated with Crohn’s disease – in 1, undifferentiated spondyloarthritis – in 16. Most patients, along with nonsteroidal anti-inflammatory drugs, received glucocorticoids, basic anti-inflammatory drugs, and biological drugs. Patients were interviewed by a research doctor with the completion of a unified questionnaire, additional data were obtained from medical documentation.Results. 20% of patients reported more frequent CI development after the SpA debut. 28.7% of patients reported a more severe course of previously observed CI. Temporary discontinuation of therapy due to the development of CI occurred in 25.4% of patients. Exacerbation of SpA after CI was diagnosed in 40% of patients. In general, the leading place in the structure of CI was occupied by infections of the respiratory tract and ENT-organs, the second place belonged to herpes-viral infections. Serious CI accounted for 6.8% of all cases of CI. In SpA patients receiving immunosuppressive therapy, there was an increase in the frequency of acute nasopharyngitis, sinusitis, acute bronchitis, pneumonia and herpes-viral infections. However, cases of CI have also been reported in patients who have never received immuno-suppressive drugs.Conclusion. The data obtained indicate the important of the problem of CI in SpA. Further studies are needed on large samples of patients in order to find significant risk factors for CI, study their relationship with clinical characteristics and influence on the course of SpA.https://www.med-sovet.pro/jour/article/view/6020comorbid infectionsspondyloarthritisankylosing spondylitispsoriatic arthritisimmunosuppressive therapybiological agents
spellingShingle M. M. Baranova
N. V. Muravyeva
B. S. Belov
The frequency and structure of comorbid infections in patients with spondyloarthritis (preliminary own data)
Медицинский совет
comorbid infections
spondyloarthritis
ankylosing spondylitis
psoriatic arthritis
immunosuppressive therapy
biological agents
title The frequency and structure of comorbid infections in patients with spondyloarthritis (preliminary own data)
title_full The frequency and structure of comorbid infections in patients with spondyloarthritis (preliminary own data)
title_fullStr The frequency and structure of comorbid infections in patients with spondyloarthritis (preliminary own data)
title_full_unstemmed The frequency and structure of comorbid infections in patients with spondyloarthritis (preliminary own data)
title_short The frequency and structure of comorbid infections in patients with spondyloarthritis (preliminary own data)
title_sort frequency and structure of comorbid infections in patients with spondyloarthritis preliminary own data
topic comorbid infections
spondyloarthritis
ankylosing spondylitis
psoriatic arthritis
immunosuppressive therapy
biological agents
url https://www.med-sovet.pro/jour/article/view/6020
work_keys_str_mv AT mmbaranova thefrequencyandstructureofcomorbidinfectionsinpatientswithspondyloarthritispreliminaryowndata
AT nvmuravyeva thefrequencyandstructureofcomorbidinfectionsinpatientswithspondyloarthritispreliminaryowndata
AT bsbelov thefrequencyandstructureofcomorbidinfectionsinpatientswithspondyloarthritispreliminaryowndata
AT mmbaranova frequencyandstructureofcomorbidinfectionsinpatientswithspondyloarthritispreliminaryowndata
AT nvmuravyeva frequencyandstructureofcomorbidinfectionsinpatientswithspondyloarthritispreliminaryowndata
AT bsbelov frequencyandstructureofcomorbidinfectionsinpatientswithspondyloarthritispreliminaryowndata